{"id":"W4379981977","doi":"10.1002/hon.3164_288","title":"Indolent lymphoma: Bendamustine, rituximab and acalabrutinib in Waldenstroms Macroglobulinemia (BRAWM)","year":2023,"lang":"en","type":"article","venue":"Hematological Oncology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"Université Laval; Canadian Red Cross Society; Health Canada; Baker Hughes (Canada); Queen Elizabeth II Health Sciences Centre; Health Sciences Centre; Sunnybrook Hospital; Sunnybrook Health Science Centre; Agricultural Research Institute of Ontario; Health Sciences North; Juravinski Cancer Centre; McGill University Health Centre","funders":"","keywords":"Bendamustine; Medicine; Rituximab; Adverse effect; Internal medicine; Waldenstrom macroglobulinemia; Lymphoplasmacytic Lymphoma; Clinical trial; Ibrutinib; Oncology; Lymphoma; Leukemia; Chronic lymphocytic leukemia","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006759,0.0002784631,0.001097292,0.0003211671,0.0000807329,0.00001844569,0.0002046478,0.0006638744,0.0004257025],"category_scores_gemma":[0.001247528,0.0002131034,0.0001073068,0.0009139511,0.0005818492,0.00004915393,0.0005280265,0.0004841938,0.0008618136],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.004131575,"about_ca_system_score_gemma":0.002527685,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001359718,"about_ca_topic_score_gemma":0.0000702966,"domain_scores_codex":[0.9969612,0.0001882982,0.0006787502,0.0007143697,0.0004363289,0.001021039],"domain_scores_gemma":[0.9980555,0.0009694719,0.0001010065,0.0003745177,0.00008630173,0.000413262],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.01196844,0.01327874,0.1518832,0.00431562,0.0005964723,0.2285918,0.00323987,0.00008707686,0.01264362,0.04823191,0.1148695,0.4102937],"study_design_scores_gemma":[0.3740602,0.009288019,0.2683598,0.001076378,0.0003391983,0.08166604,0.003042649,0.06714571,0.007978176,0.007697293,0.1773606,0.001985848],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9854445,0.0005391562,0.00001845324,0.006039508,0.0001734655,0.0006582051,0.000009682878,0.000288601,0.006828437],"genre_scores_gemma":[0.9962827,0.0005226288,0.001231137,0.0009458559,0.0001333413,0.0001318829,0.00005526897,0.00002979683,0.0006673969],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4083078,"threshold_uncertainty_score":0.9999161,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0431760209306247,"score_gpt":0.370445165895174,"score_spread":0.3272691449645493,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}